Alcohol advice tightens after low-dose risk findings

Researchers reviewing federally backed evidence on alcohol and health have recommended that adults consume no more than one alcoholic drink a day, after finding no net health benefit from even low levels of regular drinking.

The findings sharpen a long-running public health debate over whether moderate drinking can be considered safe or beneficial. The work, commissioned to inform the 2025-2030 US dietary advice, found that one drink a day was linked to higher lifetime risks from alcohol-related causes, including cancers, liver disease, injuries and road accidents, while any protective signals for some cardiovascular or metabolic conditions were limited, inconsistent or vulnerable to bias.

The final study was published on 9 June 2026 in the Journal of Studies on Alcohol and Drugs after an earlier draft had circulated during the previous dietary guidelines process. Its release has revived scrutiny of how alcohol evidence is weighed by policymakers, particularly after the latest US guidelines moved away from the older numerical limits of one drink a day for women and two for men, replacing them with a broader message that people should consume less alcohol for better health.

The central recommendation emerging from the research is a single daily limit for adults, regardless of sex. That marks a significant shift from earlier guidance that allowed a higher ceiling for men. Scientists involved in the assessment found that risk climbed with each additional drink and that the balance of evidence did not support telling the public that low or moderate drinking improves overall health.

A standard drink in the US is generally defined as containing 14 grammes of pure alcohol, roughly equivalent to a 12-ounce beer, a five-ounce glass of wine or a 1.5-ounce measure of distilled spirits. The study examined average consumption at one, two and three drinks a day and also considered lower weekly drinking patterns. At one drink a day, elevated risks appeared for several conditions. At two drinks a day, the burden rose more sharply, particularly for liver cirrhosis, oesophageal cancer, injuries and stroke.

For men, one daily drink was associated with higher relative risk for oesophageal cancer, liver cirrhosis, oral cancer, unintentional injury and road injury. For women, one daily drink was associated with higher relative risk for liver cirrhosis, oesophageal cancer, liver cancer, injuries and oral cancer. Some lower risks were observed for diabetes and ischaemic stroke in parts of the analysis, but the broader risk picture strengthened as alcohol intake rose.

Cancer risk has become the most forceful part of the alcohol debate. A major global evidence review published in Nature Health found harmful associations between alcohol use and nine cancers, with risk increasing steadily as consumption rose. Even intake below 10 grammes a day was associated with higher risk for cancers of the pharynx, colorectum, larynx, lip and oral cavity, oesophagus, breast, liver, pancreas and prostate. Those cancers accounted for 5.6% of global deaths in 2021.

The findings add weight to a wider reassessment of the once-common view that moderate drinking, especially wine consumption, may protect the heart. Older observational studies often compared moderate drinkers with abstainers, but critics argue that such comparisons can be distorted when former drinkers who quit because of illness are grouped with lifelong non-drinkers. Differences in income, diet, exercise, smoking and access to healthcare can also make moderate drinkers appear healthier for reasons unrelated to alcohol.

The National Academies’ separate review of moderate alcohol consumption, completed for the same policy cycle, reached a more mixed assessment. It found some associations between moderate drinking and lower all-cause mortality or cardiovascular outcomes, but also found higher breast cancer risk and acknowledged major research gaps. None of its conclusions reached a high level of certainty, reflecting the limits of observational evidence in a field where long-term randomised trials are difficult to conduct.

Public health groups have criticised the removal of clear daily limits from the 2025-2030 dietary advice, arguing that broad language gives consumers too little practical guidance. Liver specialists have warned that alcohol-related disease has been rising and that guidance should account for sex-based differences in metabolism and vulnerability to harm. Industry groups have challenged stricter recommendations, saying some analyses overstate risks and underplay potential protective associations.